Chemoprevention of Gastric Cancer: Metformin
Metformin is a first-line anti-diabetic drug that has been widely used in patients with type 2 diabetes. Many population-based epidemiologic studies have shown that metformin treatment is associated with decreased risk for various cancers. Recent epidemiologic studies showed that the use of metformi...
Saved in:
Main Authors: | Young-Il Kim (Author), Soo-Jeong Cho (Author) |
---|---|
Format: | Book |
Published: |
Yong Chan Lee,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chemoprevention of Gastric Cancer: Statins
by: Sang Hyeon Choi, et al.
Published: (2017) -
Chemoprevention of Gastric Cancer: Helicobacter pylori Eradication
by: Eun Jin Kim, et al.
Published: (2017) -
Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality
by: Young-Il Kim, et al.
Published: (2017) -
Metformin and Chemoprevention: Potential for Heart-Healthy Targeting of Biologically Aggressive Breast Cancer
by: Veronica C. Jones, et al.
Published: (2020) -
Chemoprevention of Gastric Cancer: Non-steroidal Anti-inflammatory Drugs Including Aspirin
by: Kee Don Choi
Published: (2017)